Capital B is asking shareholders to approve up to $122 billion in capital-raising authority to accelerate its Bitcoin treasury strategy.

Latest NewsRead More

You might also be interested in reading FDA grants tentative approval for Amneal generic of Bausch Health’s Xiafan.